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Abstract: (195 words) Aim, Methods, Results and Conclusion 
Postpartum haemorrhage rates have been increasing in NSW and internationally, and blood transfusion 
is required in severe cases. Using routinely collected, administrative data provides a convenient method 
with which to monitor trends in both postpartum haemorrhage and transfusion use in its management. 
In order for this to be feasible however, the reliability of reporting of the conditions needs to be 
assessed.  
This study uses linked data to compare the reporting of PPH with transfusion as reported in the NSW 
Admitted Patients Data Collection (hospital data), with the same information obtained from the 
Perinatal Data Collection (birth data), for births in NSW between 2007 and 2010. 
The rate of postpartum haemorrhage requiring blood transfusion was 1.0% based on the hospital data 
and 1.1% from birth data, with a rate of 1.7% if identifying cases from either source.  Agreement 
between the two sources improved from fair to moderate over the time period. 
Postpartum haemorrhage requiring transfusion recorded in the birth data shows only moderate 
agreement with hospital data, so caution is recommended when using this variable for analysis. Linkage 
of both datasets is recommended to identify postpartum haemorrhage with transfusion until further 
validation work has been undertaken. 
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Introduction 
An important application of population health data is identifying and monitoring trends in 
adverse outcomes, which may require further investigation or intervention.1-3 In maternal 
health, one commonly monitored adverse outcome of childbirth is severe postpartum 
haemorrhage (PPH). Postpartum haemorrhage involves excessive blood loss post-
childbirth. Severity of PPH is commonly defined by quantity of blood lost, however this 
can be difficult to estimate,4 so blood product transfusion has become widely used as a 
marker of severe maternal morbidity associated with childbirth. In combination with 
routinely collected population data collections this marker has been used to monitor 
changes in morbidity over time, providing a timely and cost effective way of monitoring 
trends. 5, 6 In order for a marker to be a good indicator of the health of the population, it 
needs to be reported reliably and in a timely fashion.7-10  
Currently, local studies reporting PPH requiring transfusion use hospital diagnosis and 
procedure codes recorded in hospital separation data.11 While ascertainment of both 
PPH (Sensitivity 73.8%, specificity 98.9%) and transfusion (Sens 83.1%, spec 99.9%) is 
relatively high,12 hospital data are not the best source of birth data. Identifying birth 
admissions from hospital records relies on the presence of a diagnosis code identifying 
a live or stillbirth, which differs in reliability when there are multiple births and according 
to birth outcome and has been shown to miss some births identified in legislated birth 
data.13, 14 Additionally, hospital data lack detail on parity, gestation and obstetric history 
which are important risk factors for PPH. Use of hospital records requires linkage to the 
birth data to accurately identify hospitalisations related to a pregnancy or birth. This 
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affects the timeliness of the data, with linked births and hospitals data available 12-18 
months later than birth data alone. Birth records, collected by midwives at the time of 
birth are more timely, available after 12 months, and do not require linkage in order to 
identify births.  In 2007, NSW birth data collections included a new variable ‘PPH 
requiring transfusion’.  The reliability of this variable has not yet been assessed. This 
project compares the reporting of PPH and blood transfusion in the hospital records with 
the new variable in the birth data. 
Methods 
Births were identified from the Perinatal Data Collection (‘birth data’), a statutory 
collection of all births in NSW of at least 20 weeks gestation or 400g birthweight. 
Hospital birth admissions were identified from the Admitted Patient Data Collection 
(‘hospital data’) which is a census of all public and private hospital separations in NSW, 
containing information on procedures and diagnoses, coded according to the 10th 
revision of the International Classification of Diseases, Australian Modification (ICD10-
AM), and the Australian Classification of Health Interventions (ACHI). Probabilistic 
record linkage between the birth and hospital data was carried out by the NSW Centre 
for Health Record Linkage. All women giving birth in NSW hospitals between 2007 and 
2010, where a corresponding hospital birth record was available, were included in this 
study. Of the 371,224 linked birth records, 205 (0.1%) were missing information on birth 
data reporting of PPH requiring transfusion. 
The birth data is collected by the attending midwife or medical practitioner including 
demographic and medical information on the mother, as well as information on the 
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labour, delivery and infant. PPH requiring transfusion is recorded if there was a 
“postpartum haemorrhage requiring transfusion of whole blood or packed cells”.15 
In the hospital data, blood transfusion was defined as a record of transfusion of packed 
cells or whole blood in any of the first 20 procedure codes in the maternal birth 
admission. Similarly, PPH according to the hospital data was defined as a diagnosis of 
PPH in any of the first 20 diagnosis fields. PPH in women requiring transfusion has a 
sensitivity of 92.5%.12 Hospitals were categorised by location, public/private status and 
annual number of deliveries.  
As neither hospital nor birth data could be considered a ‘gold standard’ for PPH and 
transfusion reporting, we assessed agreement based on kappa statistics, and compared 
characteristics of discordant cases. Kappa statistics were classified as follows: near 
perfect (81-100), excellent (61-80), moderate (41-60), fair (21-40), slight (1-21) and no 
agreement (<0). 
Results 
Between 2007 and 2010 there were 370,961 births recorded in the linked hospital and 
birth data where the birth data field for PPH requiring transfusion was completed. Based 
on the hospital data the rate of PPH was 7.6%, and the rate of transfusion of packed 
cells was 1.4%. The rate of PPH requiring blood transfusion was 1.0% based on the 
hospital data and 1.1% according to the birth data (Table 1). In the hospital data, blood 
transfusion rates increased from 1.4% in 2007 to 1.5% in 2010 (p=0.006), PPH rates 
increased from 7.1% to 7.8% (p<0.0001) and the combination of PPH and transfusion 
increased from 1.0% to 1.1% (p=0.02). In the birth data, PPH with transfusion increased 
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from 1.2% to 1.3% (p=0.03). When considering identification from either source, the rate 
of PPH requiring blood transfusion was 1.7%. In hospitals with an average of over 50 
births per year, the rates of women with PPH requiring transfusion as recorded in the 
birth data ranged between (0.13%,5.63%), and in the hospital data between (0,2.31%). 
The range of differences between birth data and hospital data was (-1.33%,4.24%). 
Sensitivity analysis was undertaken to determine if concordance differed between 
vaginal and caesarean births, however rates were similar (data not shown). 
Overall the two variables had moderate agreement (kappa=0.45) (Table 2). Agreement 
tended to increase between 2007 and 2010, and was higher in tertiary and regional 
hospitals (Table 2). Twenty (17%) of the 116 hospitals reported PPH with transfusion 
with near perfect agreement. The proportion of hospitals reporting near perfect 
agreement increased from 15% in 2007 to 31% in 2010, while those reporting slight/fair 
agreement decreased from 30% in 2007 to 15% in 2010. This increase in agreement 
was due to increased reporting in the birth data, with the proportion of PPH with 
transfusion identified in the hospital data alone decreasing from 30.3% in 2007 to 22.9% 
in 2009, and those reported in both data sources increasing from 20.9% to 36.5% 
(Table 3). 
PPH with transfusion was more likely to be reported only in the birth data than hospital 
data for private patients (39.6% vs 18.9%), primiparae (29.4% vs 24.9%), pre-labour 
caesareans (17.5% vs 11.8%) and for births in regional hospitals (47.4% vs 9.7%) 
(Table 3), and less likely to be reported for multiple births (2.7% vs 4.3%), Caesarean 
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section with labour (11.2% vs 14.8%) and births at tertiary obstetric hospitals (13.9% vs 
63.3%).  
Of women reported in the birth data to have had a PPH requiring transfusion, 68% of 
women were recorded in the hospital data as having a PPH, and 53% were recorded in 
the hospital data as having received a blood transfusion. Hospital data reporting 
indicated that 236 (10.0%) of the discordant birth data records indicating a PPH 
requiring transfusion had occurred may be for haematomas or antepartum/intrapartum 
bleeding. Sixty-eight (2.9%) of records identified as PPH with transfusion in the birth 
data had a record of transfusion of another blood product recorded in the hospital data. 
 
Discussion 
We compared the new ‘PPH requiring transfusion’ variable reported in the birth data, 
with the previously validated PPH with transfusion from the hospital data and 
demonstrated moderate agreement. PPH with transfusion in the hospital data is known 
to have sensitivity of 92.5%.12 Assuming this rate of underreporting in the hospital data, 
having observed 3805 admissions with PPH and transfusion, we would expect the true 
number to be around 4114, resulting in a PPH with transfusion rate of 1.1%. In the birth 
data we observed a similar rate of 1.1%. Considering identification in either source 
(1.7%) however, would lead to a possible 55% overestimation. We also noted an 
increase in reliability of the birth data in later years. This was associated with improved 
reliability in a small number of hospitals, particularly in hospitals with a research interest 
around postpartum haemorrhage or transfusion.  
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Differences in the collection of data may explain some of the variation. Birth data is 
collected by the midwives and clinicians attending the birth, with the variable ‘PPH 
requiring transfusion’ being recorded as a check box on an electronic data entry form. In 
the hospital data, both transfusion and PPH are coded by hospital coders based on 
notes written in the medical record. PPH can only be coded from the medical record if it 
is specifically written as such in the notes.   
The lower reporting of PPH with transfusion in birth data following more complex birth 
situations (multiple births, after caesarean section following labour, and at tertiary 
obstetric facilities) may be related to differences in data recording. Obstetric staff 
compiling birth data may not have details available of events occurring outside labour 
ward, whereas medical coding departments may have additional information from 
operation reports. Validation studies have demonstrated that birth data are more 
accurately report labour and delivery factors than subsequent events,7 and that 
procedures (eg transfusion) are well ascertained in hospital data.7 
Some of the discordant records may relate to misclassification of transfusion type or 
timing. A French study compared the reporting of transfusion in a birth database with 
records from the blood bank,16  treating the blood bank data as the gold standard, 
finding sensitivity of 61.4%, and positive predictive value 82.2%, with kappa 0.7. In their 
study, birth records misclassified as blood transfusion were typically transfusion of 
another blood product (other than red cells) or other product for bleeding. This was also 
the case in our study. In the French study, transfusions not recorded in the birth record 
were for transfusions outside of the obstetric department (ICU, during transfers between 
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hospitals) or were miscoding. Importantly, the birth data imply that a transfusion 
occurred post-haemorrhage, however the timing of diagnoses and procedures recorded 
in the hospital data cannot be ascertained. It is possible that some of the transfusions 
recorded in the hospital data occurred for antepartum rather than postpartum 
haemorrhage. An earlier study using NSW hospital data indicated that 75% of obstetric 
transfusions were for postpartum haemorrhage and a further 8% were for antepartum 
haemorrhage (occurring prior to birth).17  
Population health datasets can provide a rich source of data for research, but their 
usefulness is limited by the quality of the data they contain.8-10, 12 Previous studies have 
shown that accepting diagnoses from more than one data source can increase 
ascertainment, without increasing false positives,10, 18, 19 however this is not always the 
case, and this study suggests that identifying PPH with transfusion from either birth or 
hospital data would result in over-ascertainment of around 55%. 
This study used one dataset (hospital data) to validate another dataset (birth data). 
While this allows for an initial assessment of the reliability of the birth data variable, an 
ideal assessment would have been to use a ‘gold standard’ such as medical record 
review for validation.  However, such validation studies are resource intensive and 
difficult to justify for single, relatively rare outcomes. Previous validation studies have 
shown that PPH and transfusion are underreported in the hospital data.12  
We have shown that the new variable “PPH requiring transfusion” being collected on the 
birth data shows only moderate agreement with hospital data. We would therefore 
recommend that researchers use the birth data variable with caution until further 
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validation has been undertaken. Where possible birth data linked with hospital data can 
be used to identify PPH with transfusion. An advantage of this approach is that, 
although there is some under-ascertainment, these data have already been validated. 
The changes in ascertainment over time in the birth data indicate that early years of 
data collected on PPH requiring transfusion should be excluded from trend analysis, to 
prevent improved ascertainment being interpreted as a change in incidence. 
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Table 1 Concordance of PPH with transfusion cases identified from hospital data or birth data 
  Hospital data  
  Yes No Total 
Birth data Yes 1800(0.5%) 2371(0.6%) 4171 (1.1%) 
No 2005(0.5%) 364785(98.3%) 366790 (98.9%) 
 Total 3805(1.0%) 367156 (99.0%) 370961 (100%) 
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Table 2 Agreement between birth data and hospital data 
Group Kappa Agreement 
Overall 44.6 (43.2,45.9) Moderate 
 
Mode of delivery 
Vaginal Deliveries 44.3 (42.7,45.9) Moderate 
Caesarean Deliveries  45.3 (42.7,47.) Moderate 
 
Year 
2007 36.6 (33.9,39.3) Fair agreement 
2008  36.3 (33.4,39.1) Fair agreement 
2009  43.9 (41.1,46.7) Moderate 
2010  59.2 (56.8,61.7) Moderate 
 
Hospital type 
Tertiary Obstetric 48.9 (46.8,51.1) Moderate 
Regional 46.7 (44.2,49.1) Moderate 
Urban/other 35.9 (31.7,40.0) Fair agreement 
Private 37.0 (33.9,40.2) Fair agreement 
 
Volume 
20-499 45.3 (41.6,48.9) Moderate 
500-999 46.0 (42.5,49.5) Moderate 
1000+ 44.2 (42.6,45.8) Moderate 
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Table 3 Comparison PPH with transfusion codes identified in either the birth data, hospital data or 
both. 
 Variable Both 
N (%) 
Hospital data only 
N (%) 
Birth data only 
N (%) 
p value 
Overall   1800 (100.0) 2005 (100.0) 2371 (100.0)   
Year*          
 2007 376 ( 20.9) 546 ( 27.2) 719 ( 30.3) <.0001 
 2008 335 ( 18.6) 556 ( 27.7) 589 ( 24.8)   
 2009 432 ( 24.0) 559 ( 27.9) 519 ( 21.9)   
 2010 657 ( 36.5) 344 ( 17.2) 544 ( 22.9)   
Age          
 <20 years 100 ( 5.6) 95 ( 4.7) 124 ( 5.2) 0.0371 
 20-24 259 ( 14.4) 330 ( 16.5) 335 ( 14.1)   
 25-29 460 ( 25.6) 532 ( 26.5) 609 ( 25.7)   
 30-34 530 ( 29.4) 573 ( 28.6) 740 ( 31.2)   
 35-39 357 ( 19.8) 373 ( 18.6) 480 ( 20.2)   
 40+ 94 ( 5.2) 102 ( 5.1) 83 ( 3.5)   
Multiple birth           
 Yes 78 ( 4.3) 87 ( 4.3) 63 ( 2.7) 0.003 
 No 1722 ( 95.7) 1918 ( 95.7) 2308 ( 97.3)   
Primip           
 Yes 468 ( 26.0) 500 ( 24.9) 696 ( 29.4) 0.0026 
 No 1332 ( 74.0) 1505 ( 75.1) 1675 ( 70.6)   
Gestational age           
 20-32 77 ( 4.3) 82 ( 4.1) 67 ( 2.8) 0.0059 
 33-36 142 ( 7.9) 159 ( 7.9) 149 ( 6.3)   
 37+ 1560 ( 86.7) 1732 ( 86.4) 2130 ( 89.8)   
Delivery type           
 Normal vaginal delivery 894 ( 49.7) 996 ( 49.7) 1238 ( 52.2) 0.1512 
 Caesarean section (total) 512 ( 28.4) 533 ( 26.6) 680 ( 28.7) 0.2586 
 CS- No Labour 234 ( 13.0) 237 ( 11.8) 415 ( 17.5) <.0001 
 CS-Labour 278 ( 15.4) 296 ( 14.8) 265 ( 11.2) <.0001 
 Instrumental (total) 404 ( 22.4) 472 ( 23.5) 465 ( 19.6) 0.0048 
 Forceps 198 ( 11.0) 222 ( 11.1) 192 ( 8.1) 0.0008 
 Vacuum 206 ( 11.4) 250 ( 12.5) 273 ( 11.5) 0.531 
Private patient in public hospital          
 Yes 172 ( 9.6) 210 ( 10.5) 193 ( 8.1) 0.0275 
 No 1628 ( 90.4) 1795 ( 89.5) 2178 ( 91.9)   
Hospital Group           
 Tertiary obstetric 779 ( 43.3) 1269 ( 63.3) 330 ( 13.9) <.0001 
 Regional 594 ( 33.0) 195 ( 9.7) 1125 ( 47.4)   
 Urban/other 154 ( 8.6) 373 ( 18.6) 169 ( 7.1)   
 Private 273 ( 15.2) 168 ( 8.4) 747 ( 31.5)   
* Column (first) and row (second) percentages are presented. All other reported percentages 
are column percentages 
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Figure 1 Study population for comparison of reporting of postpartum 
haemorrhage (PPH) with transfusion between birth and hospital data 
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